[{"from": "human", "value": "Provide a brief overview of this molecule. [C][N][Branch1][C][C][C][=N][C][=C][Branch2][Ring1][Ring2][C][=C][Branch1][#C][C][=Branch1][Branch1][=C][Ring1][=Branch1][I][C][C][C][=Branch1][C][=O][O][I][I]"}, {"from": "gpt", "value": "The molecule is classified as a cholecystographic agent formed by a weak organic acid that contains a tri-iodinated benzene ring with iodine at positions 2, 4 and 6. Due to its particular structure, it presents a high degree of lipid solubility and a radiopaque property. It was developed and filed to the FDA by the company BRACCO. This drug was approved on March 15, 1962 but it is nowadays discontinued from the FDA and Health Canada. On September 22, 1981, ipodate was submitted again by the company Schering AG but it is currently under an inactive status."}]